Reference is made to the stock exchange notification of 27 May 2008 regarding the demerger of Photocure ASA with PCI Biotech Holding ASA as the acquiring company.
Completion of the demerger implies that all shareholders in Photocure will receive one share in PCI Biotech Holding for each share owned in Photocure. However, the PCI Biotech Holding shares will be subject to a reverse split in a 10:1 ratio prior to delivery. It is expected that the demerger will be registered as completed in the Register of Business Enterprises after end of trading today. In accordance with the terms of the public issue, associated capital changes in PCI Biotech Holding, as well as a reverse split of the company's shares are expected to be registered in the Register of Business Enterprises at the same time. A stock exchange notification confirming this will be issued within start of trading tomorrow.
It is expected that PCI Biotech Holding's first day of listing at Oslo Axess will be 18 June 2008.